Create a free Diverse: Issues In Higher Education account to continue reading. Already have an account? Enter your email to access the article.

Trump Has Plans for FDA

The new Trump administration is currently oscillating between two options for his head of the FDA. One is Scott Gottlieb, a right wing but accredited doctor, and a partner at one of the world’s largest venture capital funds. The other is Jim O’Neill, the managing director at Peter Thiel’s tech investment firm Mithril, and a man who once said, without irony, that the FDA should prove the efficacy of drugs after they’ve been legalized. Here are some of the topics that a Trump FDA are likely to end up tackling.